Literature DB >> 11726201

DNA methylation of the human oxytocin receptor gene promoter regulates tissue-specific gene suppression.

C Kusui1, T Kimura, K Ogita, H Nakamura, Y Matsumura, M Koyama, C Azuma, Y Murata.   

Abstract

In the human oxytocin receptor (OTR) gene, there is a CpG island from 140 bp upstream to 2338 bp downstream of the transcription start site (TSS). We investigated whether the methylation state of this region affects the transcription of the OTR gene. HepG2 derived from human hepatoblastoma, in which OTR gene transcription was suppressed, was treated with a demethylating agent, 5-azacytidine (Aza-C) for 2 days. Semiquantitative RT-PCR indicated that OTR mRNA was significantly increased by Aza-C treatment in a dose-dependent manner. We estimated the level of methylation within the CpG islands of the OTR gene in peripheral blood leukocytes, nonpregnant uterine myometrium, term uterine myometrium and liver. A 1.5-kb region located 5' upstream of the translation start site was divided into four fragments. Each was amplified by PCR after complete digestion with methylation-sensitive restriction enzyme HpaII. The amount of PCR products was largest in the liver, suggesting that this CpG island in the OTR gene is most highly methylated in liver, where the gene is always inactivated. We compared the effect of in vivo methylation of the CpG island on transcriptional activity of an OTR-reporter plasmid. The reporter gene activity of expression plasmid -2860/+1342-GL3, containing the CpG island, in HepG2 cells was suppressed to 30.6% of the control level after methylation with SssI methylase, while that of -2840/+144-GL3, without the CpG island was suppressed only to 81.4%. The deletion of the segment (MT2) where the level of methylation was most different between liver and uterus (-2860/+1342(del)MT2-GL3) rescued the suppression rate to 68.0%. These results indicate that the methylation of the CpG island in the human OTR gene promoter suppressed its transcription at least in liver and may regulate tissue specific gene expression among organs. (c) 2001 Elsevier Science.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11726201     DOI: 10.1006/bbrc.2001.6024

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  70 in total

1.  Epigenetic dysregulation of Oxtr in Tet1-deficient mice has implications for neuropsychiatric disorders.

Authors:  Aaron J Towers; Martine W Tremblay; Leeyup Chung; Xin-Lei Li; Alexandra L Bey; Wenhao Zhang; Xinyu Cao; Xiaoming Wang; Ping Wang; Lara J Duffney; Stephen K Siecinski; Sonia Xu; Yuna Kim; Xiangyin Kong; Simon Gregory; Wei Xie; Yong-Hui Jiang
Journal:  JCI Insight       Date:  2018-12-06

2.  Methylation-free site patterns along a 1-Mb locus on Chr19 in cancerous and normal cells are similar. A new fast approach for analyzing unmethylated CCGG sites distribution.

Authors:  Tatyana Azhikina; Ildar Gainetdinov; Yulia Skvortsova; Eugene Sverdlov
Journal:  Mol Genet Genomics       Date:  2006-02-25       Impact factor: 3.291

3.  Reduced DNA Methylation of the Oxytocin Receptor Gene Is Associated With Anhedonia-Asociality in Women With Recent-Onset Schizophrenia and Ultra-high Risk for Psychosis.

Authors:  Minji Bang; Jee In Kang; Se Joo Kim; Jin Young Park; Kyung Ran Kim; Su Young Lee; Kyungmee Park; Eun Lee; Seung-Koo Lee; Suk Kyoon An
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

4.  Distinct DNA methylation patterns characterize differentiated human embryonic stem cells and developing human fetal liver.

Authors:  Alayne L Brunner; David S Johnson; Si Wan Kim; Anton Valouev; Timothy E Reddy; Norma F Neff; Elizabeth Anton; Catherine Medina; Loan Nguyen; Eric Chiao; Chuba B Oyolu; Gary P Schroth; Devin M Absher; Julie C Baker; Richard M Myers
Journal:  Genome Res       Date:  2009-03-09       Impact factor: 9.043

Review 5.  The role of oxytocin in psychiatric disorders: a review of biological and therapeutic research findings.

Authors:  David M Cochran; Daniel Fallon; Michael Hill; Jean A Frazier
Journal:  Harv Rev Psychiatry       Date:  2013 Sep-Oct       Impact factor: 3.732

6.  Maternal adversities during pregnancy and cord blood oxytocin receptor (OXTR) DNA methylation.

Authors:  Eva Unternaehrer; Margarete Bolten; Irina Nast; Simon Staehli; Andrea H Meyer; Emma Dempster; Dirk H Hellhammer; Roselind Lieb; Gunther Meinlschmidt
Journal:  Soc Cogn Affect Neurosci       Date:  2016-04-22       Impact factor: 3.436

7.  DNA methylation analysis from saliva samples for epidemiological studies.

Authors:  Shota Nishitani; Sasha E Parets; Brian W Haas; Alicia K Smith
Journal:  Epigenetics       Date:  2018-08-01       Impact factor: 4.528

8.  Oxytocin receptor gene methylation: converging multilevel evidence for a role in social anxiety.

Authors:  Christiane Ziegler; Udo Dannlowski; David Bräuer; Stephan Stevens; Inga Laeger; Hannah Wittmann; Harald Kugel; Christian Dobel; René Hurlemann; Andreas Reif; Klaus-Peter Lesch; Walter Heindel; Clemens Kirschbaum; Volker Arolt; Alexander L Gerlach; Jürgen Hoyer; Jürgen Deckert; Peter Zwanzger; Katharina Domschke
Journal:  Neuropsychopharmacology       Date:  2015-01-07       Impact factor: 7.853

9.  Sex and diagnosis specific associations between DNA methylation of the oxytocin receptor gene with emotion processing and temporal-limbic and prefrontal brain volumes in psychotic disorders.

Authors:  Leah H Rubin; Jessica J Connelly; James L Reilly; C Sue Carter; Lauren L Drogos; Hossein Pournajafi-Nazarloo; Anthony C Ruocco; Sarah K Keedy; Ian Matthew; Neeraj Tandon; Godfrey D Pearlson; Brett A Clementz; Carol A Tamminga; Elliot S Gershon; Matcheri S Keshavan; Jeffrey R Bishop; John A Sweeney
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2015-11-09

10.  Genomic and epigenetic evidence for oxytocin receptor deficiency in autism.

Authors:  Simon G Gregory; Jessica J Connelly; Aaron J Towers; Jessica Johnson; Dhani Biscocho; Christina A Markunas; Carla Lintas; Ruth K Abramson; Harry H Wright; Peter Ellis; Cordelia F Langford; Gordon Worley; G Robert Delong; Susan K Murphy; Michael L Cuccaro; Antonello Persico; Margaret A Pericak-Vance
Journal:  BMC Med       Date:  2009-10-22       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.